Table 5.
Expression of the miR-17-92 cluster and paralogues in triple-negative tumors compared to others, using microarray
| MiRNA | Triple-negative tumors | Not triple-negative tumors | logFC | p* | ||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| miR-17-5p | 6.80 | 1.10 | 6.22 | 0.50 | 0.581 | 0.0029 |
| miR-20a-5p | 7.16 | 1.05 | 6.60 | 0.42 | 0.566 | 0.0021 |
| miR-92a-3p | 7.55 | 0.75 | 7.17 | 0.44 | 0.384 | 0.011 |
| miR-106b-5p | 6.84 | 0.72 | 6.50 | 0.45 | 0.341 | 0.021 |
| miR-93-5p | 7.23 | 0.76 | 6.96 | 0.51 | 0.270 | 0.094 |
| miR-25-3p | 6.66 | 0.41 | 6.51 | 0.31 | 0.147 | 0.10 |
Expression levels are given as the mean (standard deviation) of log2 transformed intensity values (Hy3) by microarray analyses
* False discovery rate (FDR) adjusted p-value